Altiratinib | m-entrepreneurship.com

Product Name :
Altiratinib

Search keywords :
Altiratinib

drugId :
null

Target Vo:
Neurotrophic tyrosine kinase receptor type 3

Target Vo Short Name :
NTRK3

Moa_Name:
Hepatocyte growth factor receptor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Deciphera

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Solid tumours

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Panitumumab (anti-EGFR) custom synthesis
StAR Antibody Description
E-Cadherin Antibody (YA470): E-Cadherin Antibody (YA470) is a non-conjugated and Rabbit origined monoclonal antibody about 97 kDa, targeting to E-Cadherin. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts